Abstract
FK506 undoubtedly improved the survival advantage of hepatic allotransplantation. Hepatic-intestinal and multivisceral transplantation has also become a feasible therapy for patients with combined intestinal and liver failure. With better understanding of the immunologic and metabolic aspects of allo- and xenotransplantation, further clinical attempts to transplant animal organs to humans may be considered with the hope for a better outcome in the very near future.
Original language | English (US) |
---|---|
Pages (from-to) | 137-152 |
Number of pages | 16 |
Journal | Clinical transplants |
State | Published - 1993 |
All Science Journal Classification (ASJC) codes
- General Medicine